Side-by-side financials for CABA and GILD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CABA | GILD |
|---|---|---|
| Market cap | - | $155.79 B |
| US-listed rank | - | #97 |
| Revenue (latest FY) | - | $29.44B |
| Net income (latest FY) | -$167.86M | $8.51B |
| Net margin | - | 28.9% |
| P/E (trailing FY) | - | 18.3 |
| SEC filings | 423 | 981 |
Full pages: Cabaletta Bio, Inc. and GILEAD SCIENCES, INC., or browse the full rankings.